Boca Raton, FL -- (SBWIRE) -- 10/17/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – TriQuint Semiconductor (NASDAQ:TQNT), Active Network Inc (NYSE:ACTV), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Harmony Gold Mining Co. (ADR) (NYSE:HMY)
TriQuint Semiconductor (NASDAQ:TQNT) opened the session at $8.40, trading in a range of $8.33 - $8.49, and closed at $8.38. The stock showed a negative performance of -0.06% in the last trading session. TriQuint Semiconductor, Inc. provides a portfolio of radio frequency (RF) solutions. The Company is a supplier of both active and passive technologies. It designs, develop and manufacture these power amplifier, switch and filters modules in-house. It focuses on three end markets in the electronic communications system industry: mobile devices, networks,
Will TQNT Get Buyers Even After The Recent Rally? Find Out Here
Active Network Inc (NYSE:ACTV) traded 2.23 million shares in the last business day while the average volume of the stock remained 3.15 million shares. The stock showed a negative movement of -0.07% to end at $14.36. The 52 week range of the stock remained $3.83 - $14.41. The Active Network, Inc. is a provider of organization-based cloud computing applications serving a range of customer groups, including business solutions, community activities, outdoors and sports. The Company operates in two segments: Technology and Marketing services.
Has ACTV Found The Bottom And Ready To Gain Momentum? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) reported 2.24 million shares were exchanged during the last trade, while the average volume is about 3.77 million shares. The stock dropped -2.57% and finished the day at $4.36. The beta of the stock is recorded at 1.65. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Why Should Investors Buy AVNR After the Recent Fall? Just Go Here and Find Out
Harmony Gold Mining Co. (ADR) (NYSE:HMY) the stock decreased -0.92% and finished the session at $3.23. Traded with volume of 2.14 million shares in the prior session and the average volume of the stock remained 4.39 million shares. Harmony Gold Mining Company Limited (Harmony) is engaged in conducting underground and surface gold mining and related activities, including exploration, processing and smelting. During the fiscal year ended June 30, 2012 (fiscal 2012), its mining operations reported total proven and probable reserves of 52.9 million ounces (including gold equivalent ounces),
Will HMY Get Buyers Even After The Recent Rally? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)